Comparative immunohistochemical study of multicystic dysplastic kidneys with and without obstruction

Claudia P Rojas1, Arnel K Urbiztondo, Jocelyn H Bruce

  • 1Department of Pathology, University of Miami, Holtz's Children's Hospital, Miami, Florida 33136, USA.

Insights

The causes of multicystic dysplastic kidney (MCDK) are unclear. This study found different molecular pathways, involving TGF-β and IGF2, in obstructive versus non-obstructive MCDK, suggesting distinct disease mechanisms.

Area of Science:

  • Nephrology
  • Developmental Biology
  • Molecular Pathology

Background:

  • Multicystic dysplastic kidney (MCDK) is a congenital kidney abnormality with an unknown etiology.
  • Not all MCDK cases involve urinary tract obstruction, suggesting diverse underlying mechanisms.

Purpose of the Study:

  • To investigate the molecular differences in obstructive and non-obstructive MCDK.
  • To compare the expression of key proteins (TGF-β, IGF2, PAX2, BCL-2, β-catenin) in MCDK subtypes and controls.

Main Methods:

  • Immunohistochemistry was used to analyze 17 MCDK cases (10 obstructive, 7 non-obstructive) and 17 controls.
  • Expression levels of TGF-β, IGF2, PAX2, BCL-2, and β-catenin were assessed in kidney tissues.

Main Results:

  • Transforming growth factor-beta (TGF-β) was negative in obstructive MCDK but positive in non-obstructive MCDK.
  • Insulin-like growth factor 2 (IGF2) was overexpressed in obstructive MCDK and underexpressed in non-obstructive MCDK.
  • PAX2, BCL-2, and β-catenin showed similar expression patterns in both obstructive and non-obstructive MCDK.

Conclusions:

  • TGF-β and IGF2 exhibit distinct expression patterns and likely operate through different mechanisms in obstructive versus non-obstructive MCDK.
  • PAX2, BCL-2, and β-catenin do not appear to differentiate between obstructive and non-obstructive MCDK subtypes.
  • These findings suggest distinct molecular pathways contribute to the development of different forms of MCDK.